- Report
- March 2023
- 147 Pages
Global
From €5871EUR$5,999USD£5,081GBP
- Report
- May 2023
- 171 Pages
Global
From €2446EUR$2,500USD£2,118GBP
- Newsletter
- September 2023
Global
From €1010EUR$1,106USD£905GBP
- Report
- July 2023
- 180 Pages
Global
From €3478EUR$3,554USD£3,010GBP
€3864EUR$3,949USD£3,345GBP
- Report
- June 2023
- 186 Pages
Global
From €5382EUR$5,500USD£4,659GBP
- Report
- March 2023
- 150 Pages
Global
From €5823EUR$5,950USD£5,040GBP
- Report
- May 2023
- 250 Pages
Global
From €4893EUR$5,000USD£4,235GBP
- Report
- March 2023
- 200 Pages
Global
From €4893EUR$5,000USD£4,235GBP
- Report
- September 2023
- 190 Pages
Global
From €2437EUR$2,490USD£2,109GBP
- Report
- April 2023
- 110 Pages
Global
From €4183EUR$4,275USD£3,621GBP
€4648EUR$4,750USD£4,023GBP
- Report
- April 2023
- 120 Pages
Global
From €4183EUR$4,275USD£3,621GBP
€4648EUR$4,750USD£4,023GBP
- Report
- April 2023
- 110 Pages
Global
From €4183EUR$4,275USD£3,621GBP
€4648EUR$4,750USD£4,023GBP
- Report
- November 2022
- 165 Pages
Global
From €4404EUR$4,500USD£3,812GBP
- Report
- April 2023
- 247 Pages
Global
From €3670EUR$3,750USD£3,176GBP
- Report
- March 2023
- 200 Pages
Global
From €3865EUR$3,950USD£3,346GBP
- Report
- November 2022
- 1018 Pages
Global
From €2446EUR$2,500USD£2,118GBP
- Newsletter
- September 2023
- 88 Pages
Global
€1290EUR$1,318USD£1,116GBP
- Report
- October 2022
- 200 Pages
Global
From €3865EUR$3,950USD£3,346GBP
- Report
- August 2022
- 214 Pages
Global
From €4696EUR$4,799USD£4,065GBP
- Report
- April 2021
- 209 Pages
Global
From €4844EUR$4,950USD£4,193GBP

Bladder cancer is a type of cancer that affects the urinary bladder. It is the sixth most common type of cancer in the United States and the fourth most common type of cancer in Europe. Symptoms of bladder cancer include blood in the urine, pain during urination, and frequent urination. Treatment options for bladder cancer include surgery, chemotherapy, radiation therapy, and immunotherapy.
The oncology market for bladder cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new treatments to improve outcomes for patients, such as targeted therapies and immunotherapies. Additionally, research is being conducted to better understand the biology of bladder cancer and to develop new diagnostic tests.
Companies in the bladder cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more